Market Analysis
The global tumor ablation market
size is projected to reach at a stellar 11.8% CAGR during the
forecast period (2023-2032).
The Tumor Ablation Market refers to the segment of the medical
device industry dedicated to developing and providing technologies and
procedures for the ablation or destruction of tumors. Tumor ablation techniques
are minimally invasive procedures that use various energy sources, such as
radiofrequency, microwave, cryoablation, high-intensity focused ultrasound
(HIFU), and laser, to target and eliminate cancerous tissue.
This market has experienced significant growth in recent years due
to several factors. One of the primary drivers is the increasing incidence of
cancer worldwide, coupled with a growing demand for less invasive treatment
options. Tumor ablation procedures offer a less traumatic alternative to
traditional surgery, resulting in shorter hospital stays, faster recovery
times, and reduced post-operative complications for patients.
The tumor ablation market is witnessing significant growth, driven
by advancements in minimally invasive procedures such as radiofrequency
ablation (RFA) and increasing adoption of liver ablation procedures. Radiofrequency
ablation, a type of tumor ablation technique,
utilizes heat generated by high-frequency alternating current to destroy
cancerous cells. This innovative approach offers several advantages, including
minimal invasiveness, reduced recovery time, and lower risk of complications
compared to traditional surgical interventions. As a result, the demand for
radiofrequency ablation procedures is on the rise, particularly for treating
liver tumors and other solid tumors.
Market Segmentation
Market Research Future report offers a comprehensive segmental
analysis of the tumor ablation market on the basis of technology,
treatment, application and end-user.
Based on technology, it is segmented into cryoablation,
irreversible electroporation, microwave, radiofrequency and others. Of these,
radiofrequency will dominate the tumor ablation market during the forecast
period. Prominent use of this technology to remove solid tumor and its
specificity has resulted to its growth. Also, this method’s efficiency is
expected to spur the segment growth. This will be followed by microwave
ablation technology that is projected to have a remunerative growth due to the
advantages provided by this technology namely optimal heating of cystic mass,
reduced procedural pain, lesser time, constancy in high temperature and bigger
tumor ablation volume.
Based on treatment, the tumor ablation market is segmented into
laparoscopic, percutaneous and surgical. Of these, surgical will dominate the
market during the forecast period owing to rising prevalence of breast and
liver cancer that needs open surgical techniques. This will be followed by the
percutaneous ablation that is projected to grow at the fastest pace.
Based on application, it is segmented into prostate cancer, bone
cancer, breast cancer, lung cancer, liver cancer and others. Of these, liver
cancer will have the largest share in the market owing to rising cases of both
bile duct as well as primary liver cancers. Of these, lung cancer will lead the
market during the forecast period owing to rising cases of the disease.
Based on end-user, the tumor ablation market is segmented into
research institute, surgical and ablation centers and hospitals. Of these,
hospitals will dominate the market due to increasing practices to visit the
hospital for well-being along with the availability of various facilities in
hospitals.
Key Players
Tumor ablation players
include
Covidien PL,
Misonix Inc.,
Galil Medical, Inc,
Biotronik,
Boston Scientific Corporation,
Neuwave Medical, Inc.,
Healthtronics Inc.,
AngioDynamics Inc.,
EDAP TMS,
Medtronic Plc., and
SonaCare Medical.
Regional Analysis
By region, the tumor ablation market covers growth opportunities
and latest trends across Americas, Europe, Asia Pacific and Middle East and
Africa. Of these, Americas will remain head and shoulders over other regions in
the market. The growth can be attributed to factors such as increasing
incidences of cancer amid rising elderly population, use of advanced healthcare
facilities, favorable reimbursement policies, and increasing awareness
regarding cancer detection as well as treatment. The tumor ablation market in
Europe will grab the second position owing to rising prevalence of cancer
coupled with increasing healthcare expenditure. The tumor ablation market in
the APAC region will grow at the fastest pace due to high demand for advanced
healthcare technologies, constantly growing investment in healthcare and rising
geriatric population. On the other hand, the tumor ablation market in the
Middle East and Africa will have a minimal share owing to poor medical
facilities, dearth of technical knowledge and underdeveloped healthcare sector.
Related Reports-
Epilepsy Diagnosis and Treatment
For more information,
Please Visit us @ Market Research Future
No comments:
Post a Comment